Bayer weighs US pharma expansion amid turnaround

Bayer is considering expanding its pharmaceutical manufacturing presence in the United States as its turnaround strategy gains momentum. The head of Bayer's pharmaceutical division indicated that the company is evaluating opportunities to increase its footprint in the world's largest drug market. This potential expansion aims to leverage the significant demand and growth opportunities within the US pharmaceutical sector to drive the company's overall recovery and future success.